Action Needed to Protect Patients with Complex Medical Conditions Over 335 patient, provider, and caregiver groups are deeply concerned with the unprecedented, experiment -- called the Medicare IPI Model -- affecting Medicare beneficiaries who take Part B-covered drugs. With IPI, Medicare has proposed layering on a new middleman between physicians and patients. Taking the form of vendors that would impose